Login Register Cart 0
Generic placeholder image

Current Enzyme Inhibition

Editor-in-Chief

ISSN (Print): 1573-4080
ISSN (Online): 1875-6662

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Modulation of Prostaglandin E2 with Natural Products for Better Management of Pain and Inflammation

Author(s): Atul R. Chopade and Suraj N. Mali*

Volume 18, Issue 2, 2022

Published on: 28 June, 2022

Page: [78 - 81] Pages: 4

DOI: 10.2174/1573408018666220513111051

« Previous Next »
[1]
Koeberle A, Werz O. Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis. Biotechnol Adv 2018; 36(6): 1709-23.
[http://dx.doi.org/10.1016/j.biotechadv.2018.02.010] [PMID: 29454981]
[2]
Burstein SH. The chemistry, biology and pharmacology of the cyclopentenone prostaglandins. Prostaglandins Other Lipid Mediat 2020; 148: 106408.
[http://dx.doi.org/10.1016/j.prostaglandins.2020.106408] [PMID: 31931079]
[3]
Lee BR, Paing MH, Sharma-Walia N. Cyclopentenone prostaglandins: Biologically active lipid mediators targeting inflammation. Front Physiol 2021; 12: 640374.
[http://dx.doi.org/10.3389/fphys.2021.640374] [PMID: 34335286]
[4]
Robinson DR. Prostaglandins and the mechanism of action of anti-inflammatory drugs. Am J Med 1983; 75(4B): 26-31.
[http://dx.doi.org/10.1016/0002-9343(83)90325-X] [PMID: 6416064]
[5]
(a)Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011; 31(5): 986-1000.
[http://dx.doi.org/10.1161/ATVBAHA.110.207449] [PMID: 21508345] ; (b)Maroon JC, Bost JW, Maroon A. Natural anti-inflammatory agents for pain relief. Surg Neurol Int 2010; 1(1): 80.
[http://dx.doi.org/10.4103/2152-7806.73804] [PMID: 21206541] ; (c)Meek IL, Van de Laar MA. E Vonkeman H. Non-Steroidal anti-inflammatory drugs: An overview of cardiovascular risks. Pharmaceuticals (Basel) 2010; 3(7): 2146-62.
[http://dx.doi.org/10.3390/ph3072146] [PMID: 27713346]
[6]
Kabir MT, Rahman MH, Shah M, et al. Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders. Biomed Pharmacother 2022; 146: 112610.
[http://dx.doi.org/10.1016/j.biopha.2021.112610] [PMID: 35062074]
[7]
Badria FA, El-Farahaty T, Shabana AA, Hawas SA, El-Batoty MF. Boswellia-curcumin preparation for treating knee osteoarthritis: A clinical evaluation. Altern Complement Ther 2002; 8(6): 341-8.
[http://dx.doi.org/10.1089/107628002761574635]
[8]
Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003; 25(2): 213-24.
[http://dx.doi.org/10.1081/IPH-120020471] [PMID: 12784914]
[9]
Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006; 30(1): 45-51.
[http://dx.doi.org/10.1177/014860710603000145] [PMID: 16387899]
[10]
Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extract: A randomized double-blind study. Am J Med 2000; 109(1): 9-14.
[http://dx.doi.org/10.1016/S0002-9343(00)00442-3] [PMID: 10936472]
[11]
Chrubasik S, Künzel O, Model A, Conradt C, Black A. Treatment of low back pain with a herbal or synthetic anti-rheumatic: A randomized controlled study. Willow bark extract for low back pain. Rheumatology (Oxford) 2001; 40(12): 1388-93.
[http://dx.doi.org/10.1093/rheumatology/40.12.1388] [PMID: 11752510]
[12]
Funk JL, Oyarzo JN, Frye JB, et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod 2006; 69(3): 351-5.
[http://dx.doi.org/10.1021/np050327j] [PMID: 16562833]
[13]
Grimm T, Chovanová Z, Muchová J, et al. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond) 2006; 3(1): 1.
[http://dx.doi.org/10.1186/1476-9255-3-1] [PMID: 16441890]
[14]
Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 1998; 3(11): 511-4.
[PMID: 9810030]
[15]
Jancśo G, Király E, Jancsó-Gábor A. Direct evidence for an axonal site of action of capsaicin. Naunyn Schmiedebergs Arch Pharmacol 1980; 313(1): 91-4.
[http://dx.doi.org/10.1007/BF00505809] [PMID: 7207640]
[16]
Koeberle A, Northoff H, Werz O. Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol. Biochem Pharmacol 2009; 77(9): 1513-21.
[http://dx.doi.org/10.1016/j.bcp.2009.02.005] [PMID: 19426689]
[17]
Albert D, Zündorf I, Dingermann T, Müller WE, Steinhilber D, Werz O. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol 2002; 64(12): 1767-75.
[http://dx.doi.org/10.1016/S0006-2952(02)01387-4] [PMID: 12445866]
[18]
Svouraki A, Garscha U, Kouloura E, et al. Evaluation of dual 5-lipoxygenase/microsomal prostaglandin E2 synthase-1 inhibitory effect of natural and synthetic acronychia-type isoprenylated acetophenones. J Nat Prod 2017; 80(3): 699-706.
[http://dx.doi.org/10.1021/acs.jnatprod.6b01008] [PMID: 28240894]
[19]
Bauer J, Kuehnl S, Rollinger JM, et al. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Ther 2012; 342(1): 169-76.
[http://dx.doi.org/10.1124/jpet.112.193847] [PMID: 22511203]
[20]
Attiq A, Jalil J, Husain K, Ahmad W. Raging the war against inflammation with natural products. Front Pharmacol 2018; 9: 976.
[http://dx.doi.org/10.3389/fphar.2018.00976] [PMID: 30245627]
[21]
Nunes CDR, Barreto Arantes M, Menezes de Faria Pereira S, et al. Plants as sources of anti-inflammatory agents. Molecules 2020; 25(16): 3726.
[http://dx.doi.org/10.3390/molecules25163726] [PMID: 32824133]
[22]
Lima IV, Bastos LF, Limborço-Filho M, Fiebich BL, de Oliveira AC. Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediators Inflamm 2012; 2012: 946813.
[http://dx.doi.org/10.1155/2012/946813] [PMID: 22778499]
[23]
Jiang X, Renkema H, Pennings B, et al. Mechanism of action and potential applications of selective inhibition of microsomal prostaglandin E synthase-1-mediated PGE2 biosynthesis by sonlicromanol’s metabolite KH176m. Sci Rep 2021; 11(1): 880.
[http://dx.doi.org/10.1038/s41598-020-79466-w] [PMID: 33441600]
[24]
Koeberle A, Pollastro F, Northoff H, Werz O. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1. Br J Pharmacol 2009; 156(6): 952-61.
[http://dx.doi.org/10.1111/j.1476-5381.2009.00070.x] [PMID: 19298395]
[25]
O-Jin Oh. Hye-Young Min, Sang Kook Lee. Inhibition of inducible prostaglandin E2 production and cyclooxy-genase-2 expression by curdione from Curcuma zedoaria. Arch Pharm Res 2007; 30: 1236-9.
[http://dx.doi.org/10.1007/BF02980264] [PMID: 18038902]
[26]
Singh DP, Borse SP, Nivsarkar M. Clinical importance of nonsteroidal anti-inflammatory drug enteropathy: The relevance of tumor necrosis factor as a promising target. Transl Res 2016; 175: 76-91.
[http://dx.doi.org/10.1016/j.trsl.2016.03.014] [PMID: 27083387]
[27]
Harikrishnan H, Jantan I, Haque MA, Kumolosasi E. Anti-inflammatory effects of hypophyllanthin and niranthin through downregulation of NF-κB/MAPKs/PI3K-Akt signaling pathways. Inflammation 2018; 41(3): 984-95.
[http://dx.doi.org/10.1007/s10753-018-0752-4] [PMID: 29427163]
[28]
Chopade AR, Sayyad FJ, Pore YV. Molecular docking studies of phytocompounds from the phyllanthus species as potential chronic pain modulators. Sci Pharm 2014; 83(2): 243-67.
[http://dx.doi.org/10.3797/scipharm.1408-10] [PMID: 26839814]
[29]
Harikrishnan H, Jantan I, Haque MA, Kumolosasi E. Anti-inflammatory effects of Phyllanthus amarus Schum. Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages. BMC Complement Altern Med 2018; 18(1): 1-13.
[http://dx.doi.org/10.1186/s12906-018-2289-3] [PMID: 29295712]
[30]
Harikrishnan H, Jantan I, Alagan A, Haque MA. Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: Potential role in the prevention and treatment of inflammation and cancer. Inflammopharmacology 2020; 28(1): 1-18.
[http://dx.doi.org/10.1007/s10787-019-00671-9] [PMID: 31792765]
[31]
Beg S, Swain S, Hasan H, Barkat MA, Hussain MS. Systematic review of herbals as potential anti-inflammatory agents: Recent advances, current clinical status and future perspectives. Pharmacogn Rev 2011; 5(10): 120-37.
[http://dx.doi.org/10.4103/0973-7847.91102] [PMID: 22279370]
[32]
Chopade AR, Patil PA, Mali SN. Pharmacological aspects of Phyllanthus fraternus standardized extract (Rich in Lignans and Tannins) as a pain modulator. Open Pain J 2020; 13(1): 22-34.
[http://dx.doi.org/10.2174/1876386302013010022]
[33]
Friedman EA, Ogletree ML, Haddad EV, Boutaud O. Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease. Thromb Res 2015; 136(3): 493-503.
[http://dx.doi.org/10.1016/j.thromres.2015.05.027] [PMID: 26077962]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy